Prediction Model of Pancreatic Neoplasms in CP Patients With Focal Pancreatic Lesions
- Conditions
- Machine LearningChronic PancreatitisPancreatic Neoplasm
- Registration Number
- NCT07045181
- Lead Sponsor
- Changhai Hospital
- Brief Summary
This study aims to develop XGBoost machine learning model to predict pancreatic neoplasms in CP patients with focal pancreatic lesions.
- Detailed Description
Pancreatic neoplasms include various types, with pancreatic cancer being the most common and having a poor prognosis. Chronic pancreatitis (CP) can progress to pancreatic cancer, and detecting neoplasms in CP patients is challenging due to similar imaging and clinical presentations. Current diagnostic methods like CT and tumor markers have limitations, and endoscopic ultrasound-guided tissue acquisition has moderate sensitivity. Machine learning (ML) shows promise in medical fields, but its "black box" nature limits its application. SHapley additive exPlanations (SHAP) can provide intuitive explanations for ML models. This study aims to develop an ML model to predict pancreatic neoplasms in CP patients with focal pancreatic lesions and use SHAP to explain the model, aiding future research.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 106
- Diagnosis of chronic pancreatitis
- Patients has indeterminate focal pancreatic lesions discovered through contrast-enhanced CT scans
- Patients had incomplete clinical data
- Patients had no surgical pathology results for the focal pancreatic lesions and loss to follow-up, indicating that a final diagnosis of the focal pancreatic lesions could not been established
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diagnostic yield 10 years The diagnostic yield of XGBoost machine learning, including AUC、Sensitivity、Specificity
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Changhai Hospital
🇨🇳Shanghai, Shanghai, China
Changhai Hospital🇨🇳Shanghai, Shanghai, China